Cargando…
Pragmatic trial of an intervention to increase human papillomavirus vaccination in safety-net clinics
BACKGROUND: Human papillomavirus (HPV) infection has been causally linked to six cancers, and many disproportionately affect minorties. This study reports on the development and effectiveness of an intervention aimed at increasing HPV vaccine uptake among African American and Hispanic pediatric pati...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290601/ https://www.ncbi.nlm.nih.gov/pubmed/28153042 http://dx.doi.org/10.1186/s12889-017-4094-1 |
_version_ | 1782504664450727936 |
---|---|
author | Sanderson, Maureen Canedo, Juan R. Khabele, Dineo Fadden, Mary K. Harris, Cynthia Beard, Katina Burress, Marilyn Pinkerton, Helen Jackson, Cynthia Mayo-Gamble, Tilicia Hargreaves, Margaret K. Hull, Pamela C. |
author_facet | Sanderson, Maureen Canedo, Juan R. Khabele, Dineo Fadden, Mary K. Harris, Cynthia Beard, Katina Burress, Marilyn Pinkerton, Helen Jackson, Cynthia Mayo-Gamble, Tilicia Hargreaves, Margaret K. Hull, Pamela C. |
author_sort | Sanderson, Maureen |
collection | PubMed |
description | BACKGROUND: Human papillomavirus (HPV) infection has been causally linked to six cancers, and many disproportionately affect minorties. This study reports on the development and effectiveness of an intervention aimed at increasing HPV vaccine uptake among African American and Hispanic pediatric patients in safety-net clinics. METHODS: Formative research, community engagement, and theory guided development of the intervention. A clustered, non-randomized controlled pragmatic trial was conducted in four clinics providing healthcare for the underserved in Tennessee, U.S., with two intervention sites and two usual care sites. Patients aged 9-18 years (N = 408) and their mothers (N = 305) enrolled, with children clustered within families. The intervention consisted of two provider/staff training sessions and provision of patient education materials, consisting of a video/flyer promoting HPV vaccine. Medical records were reviewed before/after the initial visit and after 12 months. RESULTS: At the initial visit, provision of patient education materials and provider recommendation were higher at intervention sites versus usual care sites, and receipt of HPV vaccine was higher at intervention sites (45.4% versus 32.9%) but not significantly after adjusting for patient’s age and mother’s education. Provider recommendation, but not education materials, increased the likelihood of vaccine receipt at the initial visit, although over one-third of intervention mothers cited the flyer/video as motivating vaccination. Completion of the 3-dose series at follow-up was lower in the intervention arm. CONCLUSIONS: Future interventions should combine patient education, intensive provider/staff education, and patient reminders. Research should compare patient education focusing on HPV vaccine only versus all adolescent vaccines. TRIAL REGISTRATION: Retrospectively registered with ClinicalTrials.gov NCT02808832, 9/12/16 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12889-017-4094-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5290601 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-52906012017-02-09 Pragmatic trial of an intervention to increase human papillomavirus vaccination in safety-net clinics Sanderson, Maureen Canedo, Juan R. Khabele, Dineo Fadden, Mary K. Harris, Cynthia Beard, Katina Burress, Marilyn Pinkerton, Helen Jackson, Cynthia Mayo-Gamble, Tilicia Hargreaves, Margaret K. Hull, Pamela C. BMC Public Health Research Article BACKGROUND: Human papillomavirus (HPV) infection has been causally linked to six cancers, and many disproportionately affect minorties. This study reports on the development and effectiveness of an intervention aimed at increasing HPV vaccine uptake among African American and Hispanic pediatric patients in safety-net clinics. METHODS: Formative research, community engagement, and theory guided development of the intervention. A clustered, non-randomized controlled pragmatic trial was conducted in four clinics providing healthcare for the underserved in Tennessee, U.S., with two intervention sites and two usual care sites. Patients aged 9-18 years (N = 408) and their mothers (N = 305) enrolled, with children clustered within families. The intervention consisted of two provider/staff training sessions and provision of patient education materials, consisting of a video/flyer promoting HPV vaccine. Medical records were reviewed before/after the initial visit and after 12 months. RESULTS: At the initial visit, provision of patient education materials and provider recommendation were higher at intervention sites versus usual care sites, and receipt of HPV vaccine was higher at intervention sites (45.4% versus 32.9%) but not significantly after adjusting for patient’s age and mother’s education. Provider recommendation, but not education materials, increased the likelihood of vaccine receipt at the initial visit, although over one-third of intervention mothers cited the flyer/video as motivating vaccination. Completion of the 3-dose series at follow-up was lower in the intervention arm. CONCLUSIONS: Future interventions should combine patient education, intensive provider/staff education, and patient reminders. Research should compare patient education focusing on HPV vaccine only versus all adolescent vaccines. TRIAL REGISTRATION: Retrospectively registered with ClinicalTrials.gov NCT02808832, 9/12/16 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12889-017-4094-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-02-02 /pmc/articles/PMC5290601/ /pubmed/28153042 http://dx.doi.org/10.1186/s12889-017-4094-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Sanderson, Maureen Canedo, Juan R. Khabele, Dineo Fadden, Mary K. Harris, Cynthia Beard, Katina Burress, Marilyn Pinkerton, Helen Jackson, Cynthia Mayo-Gamble, Tilicia Hargreaves, Margaret K. Hull, Pamela C. Pragmatic trial of an intervention to increase human papillomavirus vaccination in safety-net clinics |
title | Pragmatic trial of an intervention to increase human papillomavirus vaccination in safety-net clinics |
title_full | Pragmatic trial of an intervention to increase human papillomavirus vaccination in safety-net clinics |
title_fullStr | Pragmatic trial of an intervention to increase human papillomavirus vaccination in safety-net clinics |
title_full_unstemmed | Pragmatic trial of an intervention to increase human papillomavirus vaccination in safety-net clinics |
title_short | Pragmatic trial of an intervention to increase human papillomavirus vaccination in safety-net clinics |
title_sort | pragmatic trial of an intervention to increase human papillomavirus vaccination in safety-net clinics |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290601/ https://www.ncbi.nlm.nih.gov/pubmed/28153042 http://dx.doi.org/10.1186/s12889-017-4094-1 |
work_keys_str_mv | AT sandersonmaureen pragmatictrialofaninterventiontoincreasehumanpapillomavirusvaccinationinsafetynetclinics AT canedojuanr pragmatictrialofaninterventiontoincreasehumanpapillomavirusvaccinationinsafetynetclinics AT khabeledineo pragmatictrialofaninterventiontoincreasehumanpapillomavirusvaccinationinsafetynetclinics AT faddenmaryk pragmatictrialofaninterventiontoincreasehumanpapillomavirusvaccinationinsafetynetclinics AT harriscynthia pragmatictrialofaninterventiontoincreasehumanpapillomavirusvaccinationinsafetynetclinics AT beardkatina pragmatictrialofaninterventiontoincreasehumanpapillomavirusvaccinationinsafetynetclinics AT burressmarilyn pragmatictrialofaninterventiontoincreasehumanpapillomavirusvaccinationinsafetynetclinics AT pinkertonhelen pragmatictrialofaninterventiontoincreasehumanpapillomavirusvaccinationinsafetynetclinics AT jacksoncynthia pragmatictrialofaninterventiontoincreasehumanpapillomavirusvaccinationinsafetynetclinics AT mayogambletilicia pragmatictrialofaninterventiontoincreasehumanpapillomavirusvaccinationinsafetynetclinics AT hargreavesmargaretk pragmatictrialofaninterventiontoincreasehumanpapillomavirusvaccinationinsafetynetclinics AT hullpamelac pragmatictrialofaninterventiontoincreasehumanpapillomavirusvaccinationinsafetynetclinics |